AstraZeneca - About the company
AstraZeneca is a public company based in Cambridge (United Kingdom), founded in 1999 by Amy NA. It operates as a Developer of pharmaceutical medicines for oncology and various chronic diseases. AstraZeneca has raised an undisclosed amount in funding. The company has 2172 active competitors, including 118 funded and 222 that have exited. Its top competitors include companies like AbbVie, Merck and Gilead.
Company Details
Developer of pharmaceutical medicines for oncology and various chronic diseases. Research activities focus on the discovery and production of therapeutics targeting cancer, cardiovascular conditions, renal disorders, metabolic diseases, respiratory ailments, and immunological conditions. The business also develops treatments for rare diseases and infectious conditions. Operations involve clinical trials and the application of data science to identify new molecular entities for medical use.
- Website
- www.astrazeneca.com
- Social
- Email ID
- *****@astrazeneca.com
- Phone Number
- +44 **********
- Registered Address
- 1, Johanne Møllers Passage, København V, 1799
Key Metrics
Founded Year
1999
Location
Cambridge, United Kingdom
Stage
Public
Latest Funding Round
Investors
Ranked
5th among 2172 active competitors
Annual Revenue
€10M - €50M as on Dec 31, 2024
Employee Count
77,642 as on Sep 30, 2026
Exit Details
Public
Legal entities associated with AstraZeneca
AstraZeneca is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
ASTRAZENECA A/S CIN: 55742928 , Denmark, Active | May 07, 1943 | - | - | |
ASTRAZENECA D.O.O. CIN: 78608890872 , Croatia, Active | Aug 17, 2004 | €10M - €50M (As on Dec 31, 2024) | - | |
AstraZeneca Eesti OÜ CIN: 11733875 , Estonia, Active | Oct 15, 2009 | €1M - €10M (As on Dec 31, 2023) | 41 (As on Jun 30, 2024) | |
ASTRAZENECA PHARMA INDIA LIMITED CIN: L24231KA1979PLC003563 , India, Active | Jul 11, 1979 | ₹1,000+ Cr (As on Mar 31, 2026) | 58 (As on Oct 31, 2024) |
AstraZeneca's IPO details
AstraZeneca got listed on May 12, 1993.
Click here to take a look at AstraZeneca's IPO in detail
Sign up to download AstraZeneca's company profile
AstraZeneca's funding and investors
AstraZeneca has raised funding over 29 rounds. Its latest funding round was a Grant (prize money) round on Jul 04, 2025 for $*****. 1 investor participated in its latest round. AstraZeneca has 15 institutional investors.
Here is the list of recent funding rounds of AstraZeneca:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 04, 2025 | 8920648 | Grant (prize money) | 9005991 | 6641438 | 3966962 | 4895020 |
Dec 27, 2021 | 9563734 | Post IPO | 8387058 | 9243189 | 9735040 | |
May 01, 2021 | 2428733 | Grant (prize money) | 8228128 | 9937541 | 2957333 |
Access funding benchmarks and valuations. Sign up today!View details of AstraZeneca's funding rounds and investors
AstraZeneca's founders and board of directors
Founder? Claim ProfileThe founders of AstraZeneca is Amy NA. Pascal Soirot is the CEO of AstraZeneca.
Here are the details of AstraZeneca's key team members:
- Amy NA: Founder and Chairperson, Network of Women UK of AstraZeneca.
- Pascal Soirot: CEO of AstraZeneca.
View details of AstraZeneca's Founder profiles and Board Members
AstraZeneca's employee count trend
AstraZeneca has 77,642 employees as of Sep 26. Here is AstraZeneca's employee count trend over the years:
Uncover AstraZeneca's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
AstraZeneca's Competitors and alternates
Top competitors of AstraZeneca include AbbVie, Merck and Gilead. Here is the list of Top 10 competitors of AstraZeneca, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 84/100 | |
2nd | Merck 1891, Rahway (United States), Public | Manufacturer of pharmaceutical products | - | 83/100 | |
3rd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 82/100 | |
4th | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 80/100 | |
5th |  AstraZeneca 1999, Cambridge (United Kingdom), Public | Developer of pharmaceutical medicines for oncology and various chronic diseases | - | 77/100 | |
6th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 76/100 | |
7th |  Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 76/100 | |
8th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 72/100 | |
9th |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 71/100 | |
10th |  Pfizer 1849, New York City (United States), Public | Provider of pharmaceutical products for multiple disease treatments | - | 71/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on AstraZeneca's competitors? Click here to see the top ones
AstraZeneca's Investments and acquisitions
AstraZeneca has made 63 investments in companies including Summit and Syneron Bio. AstraZeneca has also acquired 24 companies including Omniose and Modella.Here is the list of investments & acquisitions:Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Nov 11, 2026 | Acquisition | 2016 | St. Louis (United States) | |
Sep 28, 2026 | Investments | 2003 | Menlo Park (United States) | |
Mar 31, 2026 | Investments | 2022 | Guangzhou (China) |
Want to know more about where corporates are investing? Sign up today!See all investments and acquisitions by AstraZeneca
Reports related to AstraZeneca
Here is the latest report on AstraZeneca's sector:
News related to AstraZeneca
Filter this listMedia has covered AstraZeneca for a total of 354 events in the last 1 year, 161 of them have been about company updates and 41 about partnerships.
•
AstraZeneca Acquires Omniose to Bolster Vaccine Development Against Serious Bacterial InfectionsMedical Dialogues•Nov 11, 2026•AstraZeneca, Omniose
•
AstraZeneca Pharma India gets interim relief from Delhi High Court in drug overcharging caseIndiatimes•Nov 03, 2026•AstraZeneca
•
•
AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026Seeking Alpha•Oct 30, 2026•AstraZeneca
•
AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker TestingBusiness Wire•Oct 28, 2026•AstraZeneca
•
AstraZeneca and Daiichi Sankyo's Enhertu Receives EU Approval for Residual Treatment in HER2+ Early Breast CancerContract Pharma•Oct 27, 2026•AstraZeneca, Daiichi Sankyo
•
Amgen Drug Combo Cuts Risk of Death by 58% in Aggressive Lung Cancer PatientsCNBC•Oct 24, 2026•Amgen, AstraZeneca, Pfizer
•
Pathos AI Closes $237 Million Investment Round Led by Bristol Myers SquibbSiliconAngle•Oct 24, 2026•Bristol-Myers Squibb, AstraZeneca, Pathos, Tempus
•
ZEGFROVY® (sunvozertinib) now available in the US for patients with previously treated non-small cell lung cancer with EGFR exon 20 insertion mutationsBusiness Wire•Oct 22, 2026•AstraZeneca
•
AstraZeneca's Ultomiris Secures Accelerated FDA Approval for IgA NephropathyEuropaWire•Oct 22, 2026•AstraZeneca
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about AstraZeneca
Explore our recently published companies
- Miljoco - Mount Clemens based, 1979 founded, Acquired company
- Simtronic Technologies - Sydney based, 2004 founded, Unfunded company
- Cameraclub - Unfunded company
- Winston Engineering - Singapore based, 1977 founded, Acquired company
- Mac's Custom Tie-Downs - Sagle based, 1993 founded, Acquired company
- Compact Office - Poland based, Unfunded company
